Maital Shemesh-Rasmussen
Fortune : 27 945 $ au 30/06/2026
Fortune : 27 945 $ au 30/06/2026
Maital Shemesh-Rasmussen is the founder of Cox Rasmussen & Co., Inc. Current jobs include Independent Director at Pluri, Inc. since 2021, Director at Healthcare Information & Management Systems Society (NC), and Chief Commercial Officer at Octave Bioscience, Inc. since 2021.
Former jobs include Director-Strategic & Product Marketing at Oracle Healthcare Acquisition Corp.
from 2013 to 2016, Global Head-Solution Marketing at Roche Pharmaceuticals (Israel) Ltd. from 2018 to 2020, and Vice President-Global Marketing at JPMorgan Chase Bank, NA (New York) from 2002 to 2007.
Education includes graduate studies at Bar-Ilan University and undergraduate studies at Ben-Gurion University of the Negev.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PLURI INC. 0,12 % | 23/04/2026 | 13 371 ( 0,12 % ) | 27 945 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PLURI INC. | Directeur/Membre du Conseil | 06/01/2021 |
Healthcare Information & Management Systems Society (NC) | Directeur/Membre du Conseil | - |
Octave Bioscience, Inc.
Octave Bioscience, Inc. Medical SpecialtiesHealth Technology Develops quantitative measurement tools | Corporate Officer/Principal | 01/02/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Roche Pharmaceuticals (Israel) Ltd.
Roche Pharmaceuticals (Israel) Ltd. Medical DistributorsDistribution Services Wholesales drugs, proprietories and sundries | Corporate Officer/Principal | 01/01/2020 |
| ORACLE HEALTHCARE ACQUISITION CORP. | Sales & Marketing | 01/01/2016 |
JPMorgan Chase Bank, NA (New York)
JPMorgan Chase Bank, NA (New York) Major BanksFinance Operates as an national bank that provides consumer and commercial banking services | Sales & Marketing | 01/01/2007 |
Cox Rasmussen & Co., Inc. | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Pluri, Inc.
Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation | Health Technology |
Oracle Healthcare Acquisition Corp.
Oracle Healthcare Acquisition Corp. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
JPMorgan Chase Bank, NA (New York)
JPMorgan Chase Bank, NA (New York) Major BanksFinance Operates as an national bank that provides consumer and commercial banking services | Finance |
Octave Bioscience, Inc.
Octave Bioscience, Inc. Medical SpecialtiesHealth Technology Develops quantitative measurement tools | Health Technology |
Healthcare Information & Management Systems Society (NC) | |
Roche Pharmaceuticals (Israel) Ltd.
Roche Pharmaceuticals (Israel) Ltd. Medical DistributorsDistribution Services Wholesales drugs, proprietories and sundries | Distribution Services |
Cox Rasmussen & Co., Inc. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national